Adverse drug events associated with sodium zirconium cyclosilicate: A real-world pharmacovigilance study based on the FAERS database.

This indicates that AEs are not limited to the early stage of medication use but are widely distributed across a longer time frame, with a decreasing trend in the frequency of occurrence over time.

also in 47,180 other papers